Page last updated: 2024-08-24

pyrrolidine dithiocarbamate and Hepatitis C

pyrrolidine dithiocarbamate has been researched along with Hepatitis C in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, KS; Chen, YM; Chuang, YL; Huang, SN; Kuo, GC; Liaw, YF; Peng, CY; Sheen, IS; Tai, DI; Tsai, SL; Yeh, CT1

Other Studies

1 other study(ies) available for pyrrolidine dithiocarbamate and Hepatitis C

ArticleYear
Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis.
    Hepatology (Baltimore, Md.), 2000, Volume: 31, Issue:3

    Topics: Adult; Aged; Antioxidants; Apoptosis; Carcinoma, Hepatocellular; Cell Line; Female; Hepatitis C; Hepatitis C Antibodies; Humans; Immunohistochemistry; Liver; Liver Neoplasms; Male; Middle Aged; NF-kappa B; Pyrrolidines; RNA, Viral; Thiocarbamates; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Viral Core Proteins

2000